The Belgian company StratiCell, a 100% subsidiary of PAT Plant Advanced Technologies, is specialized in delivering innovative solutions in safety and efficacy studies on active ingredients dedicated to the cosmetic and care industry.

Its dermal biology and in vitro skin modeling expertise offers the opportunity to constantly develop a leading-edge performance, serving the skin care products development of dermo-cosmetic brands. More than 120 customers trust StratiCell, including the greatest names of the cosmetic and dermo-pharmaceutical industry. Famous for the quality of its work, StratiCell is known as one of the European leaders on the in vitro objectification studies’ market.

StratiCell mainly proposes cellular biology tests aiming to prove the product’s efficacy on biological targets and to identify the mechanisms of action. The company provides in this way to its active ingredient producer clients an undeniable added value allowing the objectification of the claimed efficacy of their products by scientific facts and strong illustrations.

StratiCell’s activity rests on a continuous improvement process. The market’s actors being constantly looking for new concepts, original mechanisms of action and pioneering biological targets, the company needs to propose ideas, technical approaches and new tests in the thematic in accordance with the market’s tendency. Research and development are at the center of StratiCell, through internal studies financed with equity or with collaborative projects.


Learn more>


Inscrivez-vous à notre liste de diffusion et restez informé de toute l’actualité de PAT